mimics glp 1 GLP-1 GLP-1 drugs may fight addiction
Description
As global demand rises for effective metabolic therapies, GLP-1 drug development remains one of the fastest-growing segments in biopharma innovation
How retatrutide works: the first triple agonist targeting GIP, GLP-1, and glucagon receptors
In the subgroup analyses, human GLP-1 RAs, but not nonhuman GLP-1 RAs, reduced the risk of MACE in patients with HF (p interaction = 0.11)
When it comes to science-backed weight loss and metabolic health, GLP-1 & GIP are leading the charge
